Furthermore, in a randomized, placebo-controlled pre-operative window study in breast cancer patients, women with higher body mass index (BMI) and Homeostatic Model Assessment of Insulin Resistance (HOMA) indexes had a greater response to metformin as evidenced by a decrease in Ki-67 staining [81]. Here, MKI67 is linked to breast carcinoma.